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The Clinical Prognosis of the Patients Undergoing Continuous Ambulatory Peritoneal Dialysis (CAPD)
-5 Years Retrospective Study Focusing on Cardiovascular Status- 
Junko Shoda (Department of Nephrology, Saitama Medical School, Moroyama, Iruma-gun, Saitama, 350-0495 Japan)
　Continuous ambulatory peritoneal dialysis (CAPD) was developed by Popovich and Moncrief in 1975, and 
gradually spread over the world. There are about 9000 patients receiving CAPD in our country, and it is far 
small number comparing with other countries or patients receiving hemodialysis. The reasons of that have 
been discussed as social, customary, and economical characteristics in medicine in Japan. Therefore, almost no 
institution exists which manages over 100 patients receiving CAPD except our hospital. Twenty -nine patients 
starting CAPD in 1997 were observed retrospectively for 5 years in our hospital. Eleven of 29 patients withdrew 
from CAPD for the reason of repeated peritonitis, heart failure, cerebrovascular attack, dialysis failure, and so on. 
However, there is no predictive factor for withdrawing from CAPD at the start. Peritonitis, diabetes mellitus, and 
ages over 65 years old that have been thought as a risk of technical or life survival in the patients receiving CAPD, 
did not effect on the technical or life prognosis in our patients. Our clinical data was not completely compatible with 
the previous report from other countries. However, the clinical data from 5 years observation of the patients started 
CAPD in the same period, and managed in one institute with the united clinical protocol, would have a value to the 
area of peritoneal dialysis in Japan.
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1日から 12月 31日までの 1年間に腹膜透析療法を導































































(Fig. 1b)．尿素窒素（Blood Urea Nitrogen: BUN）が導
入時に継続群 (78.8±5.5 mg/dl)で有意に高値であっ






















Technical survival は 1 年 後 で は 100 ％，3 年 後 で
79.3％，5年後で 62.1％であった (Fig. 7a)．死亡は 6.8％
にあたる 2例であり，それぞれ 30ヶ月，51ヶ月の時点













Fig. 1. a) Changes in systolic blood pressure in patients receiving peritoneal dialysis. Systolic blood pressure decreased in total 
29 patients (large open circle), and patients continued peritoneal dialysis for 5 years (closed circle). In the patients who withdrew 
peritoneal dialysis (small open circle), systolic blood pressure once increased significantly and then decreased. * means p＜0.05 
compared with patients continued peritoneal dialysis for 5 years. b) Changes in diastolic blood pressure in patients receiving 
dialysis. Diastolic blood pressure decreased in all patients groups. Symbols expressed the same groups as Fig. 1a. 
Fig. 2. a) Changes in blood urea nitrogen (BUN) in patients with receiving peritoneal dialysis. BUN was significantly higher in 
patients continued peritoneal dialysis for 5 years, but there is no significant difference after then. ** means p＜0.01 compared 
with patients withdrew peritoneal dialysis. b) Changes in serum creatinine in patients with receiving peritoneal dialysis. There is 
no significant difference in all time courses. Symbols expressed the same groups as Fig. 1a.
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Fig. 3. a) Changes in daily urine volume in patients with peritoneal dialysis. Daily urine volume decreased gradually in all 
groups. b) Changes in daily drain volume of peritoneal dialysis in patients. Daily drain volume increased accompanying the 
decrease on daily urine volume. Symbols expressed the same groups as Fig. 1a.
Fig. 4. a) Changes in cardiothoratic rate (CTR) in patients receiving peritoneal dialysis. The increase on CTR increased in 
patients withdrew peritoneal dialysis and were significantly higher in year 2 and 3 than that in patients continued peritoneal 
dialysis. ** means p＜0.01 compared with patients continued peritoneal dialysis for 5 years. b) Changes in body weight in 
patients receiving peritoneal dialysis. The increase on CTR were not accompanied with the increase on body weight in patients 
withdrew peritoneal dialysis. Symbols expressed the same groups as Fig. 1a.
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Fig. 5. a) Changes in hemoglobin in patients receiving peritoneal dialysis. There is no significant difference in all time courses. 
b) Changes in monthly human recombinant erythropoietin consumption in patients receiving peritoneal dialysis. Symbols 
expressed the same groups as Fig. 1a.
Fig. 6. a) Changes in serum calcium in patients receiving peritoneal dialysis. There is no significant difference in all the time 
courses. b) Changes in serum phosphate in patients receiving peritoneal dialysis. Symbols expressed the same groups as Fig. 1a.



























Fig. 7. a) Cumulative technical survival rate in patients receiving peritoneal dialysis. b) Cumulative technical survival rate in 
patients receiving peritoneal dialysis. There is no significant difference in survival rate between the patients with peritonitis (＋: 
closed circle n＝10), and without peritonitis (－ : open circle n＝19). c) Cumulative technical survival rate in patients receiving 
peritoneal dialysis. There is no significant difference in survival rate between the patients with diabetes mellitus (＋: closed 
circle n＝6), and without diabetes mellitus (－ : open circle n＝23). d) Cumulative technical survival rate in patients receiving 
peritoneal dialysis. There is no significant difference in survival rate between the patients over 65 years (＋: closed circle n＝8), 
and under 64 years (－ : open circle n＝21).
Table 3. Changes in parameters of echocardiography
PWT: Left ventricular posterobasal free wall thickness, IVST: 
Interventricullar septal thickness, LVDs: Left ventricular 
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